KevinMD June 26, 2024
Arthur Lazarus, MD, MBA

In early 2022, during the coronavirus pandemic, I considered practicing psychiatry via telehealth. I looked into two telemental-health companies in particular—Cerebral and Done Global, Inc. (hereafter “Done”)—and turned them both down. I did not believe their ethics measured up. In the case of Done, I asked to be withdrawn from consideration as medical director because I believed the company lacked adequate infrastructure and was exclusively focused on treating patients with ADHD.

Sure enough, on June 13, 2024, executives from Done were arrested and charged with fraud. Federal authorities alleged that the founder and clinical president (a psychiatrist) orchestrated a scheme to profit from Adderall prescriptions. DEA administrator Anne Milgram wrote, “The defendants allegedly preyed on Americans and put profits over...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Mental Health, Patient / Consumer, Provider, Technology
HealthTech Frenemies: Understanding the complex relationship
Experts divided on value of physician holograms
Digital health interventions in primary care in low- and middle-income countries: a systematic scoping review protocol
Enhancing cybersecurity in healthcare's digital age
AHRQ and CDS: Building the Bridge to Evidence-based Medicine

Share This Article